To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Pfizer Licenses the IDBS BioBook™
IDBS has announced that Pfizer Global R&D has licensed the IDBS BioBook™ global electronic experiment and study management software.
BioBook is being deployed across the full spectrum of research biology; including discovery biology, worldwide safety sciences, pharmacokinetics dynamics and metabolism, and secondary and safety pharmacology.
IDBS claims that, users of BioBook can manage every aspect of their complex late stage research. As part of the global contract, BioBook will be used across all of Pfizer’s research sites worldwide, with IDBS delivering implementation and support services.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
